Point your AI agent at freehire and let it find you a job.

Get the CLI →

Veracyte

Provides genomic diagnostic tests for precise cancer diagnosis.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
biotechhealth-techmedical-devices

Company facts

Founded
2006
Employees
755
Headquarters
United States
CEO
Bonnie Anderson
Type
Public
Listed
NASDAQ: VCYT
Subsidiaries
Decipher Biosciences, HalioDx

About

At Veracyte, we believe exceptional cancer care begins with exceptional diagnostics. Our mission is clear: empower clinicians with high-value insights essential in the race to diagnose and treat various cancers, including thyroid, prostate, breast, bladder, and lung cancers, as well as interstitial lung diseases. Through our rigorous, multi-disciplinary innovation process, we identify unmet clinical needs and develop genomic tests that provide actionable insights to enhance patient care. Our innovative solutions offer clarity at critical moments during a patient’s cancer care journey, enabling informed decision-making for both clinicians and patients. Veracyte’s tests help avoid unnecessary procedures by ensuring timely and accurate diagnoses. With over 400,000 patients benefiting from our advanced molecular tests, we address the significant global challenge, as more than 7 million people are diagnosed with cancers that our tests target each year. Together with our clinical partners, we aim to elevate the standard of care and make leading diagnostics accessible worldwide, embodying our vision of transforming cancer care for patients globally.

11 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available